Transpacific TAVR Registry

Part of paid clinical trials in Stanford, California.

Sponsor
Duk-Woo Park, MD
Study ID
NCT03826264
Status
Recruiting
Apply to this trial

Conditions

  • Aortic Valve Insufficiency
  • Heart Valve Diseases

Eligibility Criteria

Sex
ALL
Age
19 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • TAVR — PROCEDURE
    transcatheter aortic valve replacement (TAVR)

Study Details

This registry evaluates the long-term outcome of Transcatheter aortic valve replacement (TAVR) in real-world clinical practice.

Key Dates

Start date
Jun 15, 2019
Status verified
Dec 2025
Primary completion
Dec 31, 2035
Completion
Dec 31, 2036

Study Design

Enrollment
10,000 participants (estimated)

Arms

  • Arm: Korea Centers
    Seoul, Korea All Patients undergoing TAVR
  • Arm: Stanford University
    California, USA All Patients undergoing TAVR
  • Arm: Northwestern University
    Evanston, Illinois, USA All Patients undergoing TAVR
  • Arm: Cheng-Hsin Hospital
    Taipei, Taiwan All Patients undergoing TAVR

Primary Outcome Measure

Event rate of all cause death [ Time Frame: 1 year ]

Central Contacts

Locations (2)

FacilityCityStateZIPSite coordinators
Stanford UniversityStanfordCalifornia94305
Alan Ching Yuen Yeung, MD
Alan Ching Yuenn Yeung, MD (PRINCIPAL_INVESTIGATOR)
Northwestern Memorial HospitalChicagoIllinois60611
James D. Flaherty, MD
James D. Flaherty, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Stanford, CA

By research site
Stanford University· Stanford, CANorthwestern Memorial Hospital· Chicago, IL

Related Studies